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Abstract
Background: The use of multiple medicines (polypharmacy) is increasingly common in older people. Ensuring that
patients receive the most appropriate combinations of medications (appropriate polypharmacy) is a significant
challenge. The quality of evidence to support the effectiveness of interventions to improve appropriate polypharmacy
is low. Systematic identification of mediators of behaviour change, using the Theoretical Domains Framework (TDF),
provides a theoretically robust evidence base to inform intervention design. This study aimed to (1) identify key
theoretical domains that were perceived to influence the prescribing and dispensing of appropriate polypharmacy to
older patients by general practitioners (GPs) and community pharmacists, and (2) map domains to associated
behaviour change techniques (BCTs) to include as components of an intervention to improve appropriate
polypharmacy in older people in primary care.
Methods: Semi-structured interviews were conducted with members of each healthcare professional (HCP)
group using tailored topic guides based on TDF version 1 (12 domains). Questions covering each domain
explored HCPs’ perceptions of barriers and facilitators to ensuring the prescribing and dispensing of appropriate
polypharmacy to older people. Interviews were audio-recorded and transcribed verbatim. Data analysis involved the
framework method and content analysis. Key domains were identified and mapped to BCTs based on established
methods and discussion within the research team.
Results: Thirty HCPs were interviewed (15 GPs, 15 pharmacists). Eight key domains were identified, perceived to
influence prescribing and dispensing of appropriate polypharmacy: ‘Skills’, ‘Beliefs about capabilities’, ‘Beliefs about
consequences’, ‘Environmental context and resources’, ‘Memory, attention and decision processes’, ‘Social/professional
role and identity’, ‘Social influences’ and ‘Behavioural regulation’. Following mapping, four BCTs were selected for
inclusion in an intervention for GPs or pharmacists: ‘Action planning’, ‘Prompts/cues’, ‘Modelling or demonstrating
of behaviour’ and ‘Salience of consequences’. An additional BCT (‘Social support or encouragement’) was selected
for inclusion in a community pharmacy-based intervention in order to address barriers relating to interprofessional
working that were encountered by pharmacists.
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Conclusions: Selected BCTs will be operationalised in a theory-based intervention to improve appropriate polypharmacy
for older people, to be delivered in GP practice and community pharmacy settings. Future research will involve
development and feasibility testing of this intervention.
Keywords: Polypharmacy, Intervention, Qualitative, Behaviour change, Prescribing, Dispensing, Theoretical
Domains Framework
Background
The use of multiple medicines, also termed polyphar-
macy, is increasingly common in older people [1, 2].
This has been attributed to several factors including the
high prevalence of multimorbidity (i.e. the presence of
two or more chronic conditions) in older populations
and the large number of evidence-based guidelines
which advocate the use of more than one drug in the
management of long-term conditions, such as hyperten-
sion [3]. Ensuring that older people receive the most ap-
propriate combinations of medications is an ongoing
challenge faced by healthcare professionals (HCPs). Poly-
pharmacy has been identified as the principal determin-
ant of potentially inappropriate prescribing for older
populations [4, 5] and linked to negative clinical conse-
quences, including adverse drug events (ADEs), drug in-
teractions and medication non-adherence [6].
Although there is no universally accepted definition of
the term ‘polypharmacy’, much of the literature to date
has been based around numerical thresholds, such as
the co-prescribing of four or five medications [6]. His-
torically, polypharmacy has been viewed negatively and
seen to signify inappropriate medication use [7]. How-
ever, recent cohort studies have challenged existing as-
sumptions that polypharmacy is always hazardous or
indicative of poor care and highlighted the need for
greater consideration of the clinical context in which
medications are prescribed [8, 9]. Accordingly, the term
‘appropriate polypharmacy’ has been promoted in place
of existing thresholds that define polypharmacy based
on the number of medications prescribed to patients [10].
Appropriate polypharmacy is defined as the ‘prescribing
for individuals with complex or multiple conditions
where medicine use has been optimised and prescribing
aligns with best evidence’ [10]. The concept of ‘appro-
priate polypharmacy’ recognises that patients can bene-
fit from multiple medications provided that prescribing
is evidence-based and reflects patients’ clinical needs.
A recently updated Cochrane review highlighted a lack
of rigorous evaluations of interventions to improve ap-
propriate polypharmacy in older people [11]. Although
the review findings supported a limited range of inter-
ventions, which were most commonly pharmaceutical
care-based and typically involved medication reviews by
HCPs, considerable limitations were identified with the
existent literature (e.g. risks of bias, insufficient details
of intervention development and delivery) [11]. In order
to address these deficiencies, it was recommended that
future research adopt a more systematic approach in de-
veloping interventions using a combination of evidence
and theory [11].
The study reported here was part of a larger multi-
phase mixed methods research project that sought to
address identified limitations of previous interventions
targeting appropriate polypharmacy in older people. The
specific aim of the project was to develop an interven-
tion using a systematic approach that was guided by the
best available evidence and appropriate theory and also
engaged key stakeholders in the provision of medications
to older patients in primary care (i.e. general practi-
tioners (GPs) and community pharmacists). This ap-
proach to intervention development was modelled on
the Medical Research Council’s (MRC) guidance for de-
veloping and evaluating complex interventions [12].
Linked components of the larger project involved the
update of a Cochrane review [11], as noted above, in
order to identify the current evidence base for interven-
tions that aimed to improve appropriate polypharmacy.
The objective of the current study was to identify the
underlying barriers to, and enablers of, prescribing/dis-
pensing appropriate polypharmacy and to frame these
barriers and enablers in terms of theoretical domains of
behaviour change to support intervention development.
The underpinning theoretical model was the Theoretical
Domains Framework (TDF) [13]. The TDF has been
used to identify key theoretical domains that are per-
ceived to influence HCPs’ behaviours and provides a the-
oretically robust evidence base to inform intervention
design. Key domains are then mapped to behaviour
change techniques (BCTs) which can form the interven-
tion’s so-called 'active ingredients' [14]. Michie et al. [15]
previously developed a matrix to aid this mapping process
using the original 12 domain TDF (TDF1) [13]. Cane et al.
[16] recently developed this work using the 14 domain
TDF (TDF2) [17] and a larger number of BCTs.
A number of previous TDF-based intervention devel-
opment studies have focussed on the implementation of
evidence-based guidelines by HCPs as the target behav-
iour [18–20]. The challenge of targeting HCPs’ clinical
behaviours to improve appropriate polypharmacy was a
Cadogan et al. Implementation Science  (2015) 10:161 Page 2 of 14
lack of evidence and guidelines to inform clinical
practice when prescribing for older patients, in whom
multimorbidity is highly prevalent [21]. This study
used the TDF to focus specifically on the prescribing
and dispensing of appropriate polypharmacy to older
patients by GPs and community pharmacists, respect-
ively, as the target behaviours. The study aimed to
identify key theoretical domains that may act as me-
diators (i.e. barriers, facilitators) of behaviour change
and to map these domains to BCTs that could be in-
corporated into an intervention to improve appropri-
ate polypharmacy in older people in primary care.
The identified intervention components (i.e. BCTs) were
used to develop an evidence-based and well-theorised
intervention (details of which will be reported in a future
publication) ready for feasibility testing at a later stage of
the project, before progressing to a larger scale evaluation
in a randomised study.
Methods
Semi-structured interviews were conducted with GPs
and community pharmacists using separate TDF-
based topic guides (Additional file 1 and Additional
file 2) to identify key theoretical domains which were
then mapped to BCTs that would be the components
of an intervention to improve appropriate polyphar-
macy in older patients. Ethical approval was granted
by the Office of Research Ethics Committees Northern
Ireland (REC reference 13/NI/0114).
Sampling and recruitment
A purposive sampling method was employed. A computer-
generated random sample of general practices from
each of five Health and Social Care Trust areas (main
administrative health areas) in Northern Ireland was
contacted by telephone by a nurse practitioner from the
Northern Ireland Clinical Research Network (NICRN).
The nurse provided a brief summary of the project and
posted a written invitation letter and information sheet
to practices that expressed interest in receiving further
information. The nurse aimed to recruit up to two GPs
from two general practices (one urban, one rural) in
each Health and Social Care Trust area to ensure geo-
graphical diversity. The nurse liaised with each practice
to arrange dates for the researcher (CC) to attend the
practice to interview GP participants.
Practice managers in recruited practices were asked
to identify local community pharmacies that dispensed
most of the practice’s prescriptions for older patients.
These pharmacies were contacted by telephone by the
researcher who provided a brief summary of the project
and posted a written invitation letter and information
sheet to those interested in receiving further informa-
tion. One community pharmacist from up to two
pharmacies associated with each participating general
practice was invited to participate. The researcher ar-
ranged interviews with pharmacist participants.
The researcher obtained written informed consent
from all participants prior to taking part in the research.
All participants were offered financial compensation for
their time (£50 cheque) and provided with a certificate
of participation for their continuing professional devel-
opment portfolios.
Semi-structured interviews
Semi-structured face-to-face interviews were conducted
by the researcher (CC) with recruited HCPs either at
their place of work or another convenient location. In-
terviews were conducted between May and October
2014. Interview topic guides were based around the 12
domains of the TDF [13] and developed through dis-
cussion amongst members of the research team. The
12-domain version of the TDF was specifically chosen
for a number of reasons. Based on preliminary discus-
sions within the research team, as well as individual
team members’ (CR, JF) previous experience in using
TDF1 [18, 19, 22], it was agreed that the ‘Nature of the
behaviours’ domain would likely be important to the
target behaviours. For example, it was felt that the ex-
tent to which prescribing and dispensing of appropriate
polypharmacy formed part of routine practices would
need to be explored using this domain which is present
in TDF1 but not in TDF2 (14 domain). In addition, we
wanted to avoid unnecessarily long interviews in order
to minimise the burden to participants and considered
TDF1 to be more parsimonious than TDF2. We were
also aware of some evidence in the literature that TDF1
does not have poorer validity than TDF2 [23].
Separate interview topic guides were developed and
piloted for each HCP group. Each topic guide com-
prised a similar line of questions covering four key
areas: (1) HCPs’ views on the term ‘polypharmacy’, (2)
HCPs’ assessment of a clinical scenario depicting an
older patient receiving inappropriate polypharmacy, (3)
HCPs’ perceptions of barriers and facilitators to ensur-
ing the prescribing (GPs) and dispensing (community
pharmacists) of appropriate polypharmacy to older
people and (4) HCPs’ views on potential intervention
components and outcome measures for inclusion in fu-
ture intervention studies. Participants’ assessments of
the clinical scenario were not included in the analysis
as the scenario was intended purely as a discussion aid
to ensure that participants understood the nature of the
target behaviours. Hence, participants were not prompted
to provide a detailed assessment of the scenario during
interviews. For other questions, prompts were used to
encourage participants to elaborate on their responses
where necessary.
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Data were audio-recorded and transcribed verbatim.
Transcripts were independently checked for accuracy,
de-identified and assigned anonymous codes to indicate
whether participants were GPs (i.e. GP01, GP02, etc.) or
pharmacists (i.e. PCT01, PCT02, etc.).
Data analysis
Each interview was analysed separately, and all tran-
scripts were analysed independently by at least two
members of the research team. An extensive familiar-
isation process was carried out which involved read-
ing and re-reading of transcripts, as well as listening
back to interview recordings. Data were analysed in
two stages. The first stage used the framework method
[24] and adopted a deductive approach using pre-defined
coding categories: (1) healthcare professionals’ definitions
of polypharmacy, (2) TDF domains (outlined further
below), and (3) potential intervention components and as-
sessment outcomes. The second stage used content ana-
lysis [25] and adopted an inductive approach in which
emerging content themes relating to barriers and facilita-
tors within each domain were identified. Transcript cod-
ing was compared and any disagreements were resolved
by consensus discussion. NVivo QSR 10 was used to man-
age the data. As the primary focus of the analysis was the
TDF-related data, the analysis of other sections of inter-
view transcripts is not reported on in this paper.
Identification of key theoretical domains
The framework method was used to systematically
index and chart the data using the 12 domains of the
TDF as the coding categories (Additional file 3) [24].
Data were indexed by two researchers working inde-
pendently. Indexed data were charted by one researcher in
a Microsoft Excel spreadsheet to generate a framework
matrix which included references to illustrative quotes.
Content analysis of the framework matrix was per-
formed, and a summary outlining subthemes/specific
beliefs within each domain was reviewed by other
members of the research team. This summary was
discussed by the research team who first identified
criteria for deciding the relevance of each domain to
the target behaviours (i.e. prescribing and dispensing
of appropriate polypharmacy). Decisions about the
relevance of each domain were guided by previous re-
search [25]; the extent to which sections of interview
transcripts were coded to each domain was reviewed
as a crude indicator of relevance, and the summary
documents were then used to determine whether par-
ticipants related the domain to the target behaviour.
Key theoretical domains for the intervention were se-
lected by the multidisciplinary research team using a
consensus-based approach. Decisions were based on
barriers and facilitators within relevant domains that
could feasibly be targeted based on the available pro-
ject resources.
Triangulation
Two kinds of triangulation were conducted: data tri-
angulation (use of multiple groups of research partici-
pants) and investigator triangulation (use of multiple
researchers in data analysis) [26]. Triangulation methods
focussed on comparing and contrasting both HCP groups’
perceptions of barriers and facilitators within each of the
theoretical domains with a view to guiding the research
team’s decisions as to how selected BCTs could eventually
be operationalised as part of an intervention.
Identification and selection of BCTs
A table of BCTs that have been reliably allocated to
the 14 domain version of the TDF [17] by a panel of
behaviour change experts was used as the primary
reference source to guide the identification and selec-
tion of BCTs to target key theoretical domains [16].
The reason for using this mapping work as the primary
reference sources was because it included a larger number
of BCTs than the original mapping matrix that was devel-
oped by Michie et al. [15]. In order to inform identifica-
tion and selection of BCTs that had not been allocated by
Cane et al. [16] to domains such as ‘Social/professional
role and identity’, the research team compared the results
of this mapping process against the original mapping
matrix [15] as a secondary reference source. The research
team reviewed all of the BCTs that had been mapped to
key domains in each reference source and reached con-
sensus as to which BCTs should be selected for inclusion
in the intervention. This selection process was guided by
the interview data. For example, if time and workload
were reported by HCPs as major barriers to the target be-
haviours, BCTs that could likely be delivered as part of a
single intervention were to be prioritised over those that
would require repeated administration or extended time
periods to elicit required changes. This was to ensure that
the intervention would be practicable for HCPs working
in clinical practice.
Results
Participants
Eighty general practices and 25 community pharmacies
were contacted about the research. Thirty HCP partici-
pants (15 GPs, 15 community pharmacists) were recruited
from nine general practices (response rate 11 %) and 15
community pharmacies (response rate 60 %) across each
of the five Health and Social Care Trust areas in Northern
Ireland (Table 1). Despite repeated efforts by NICRN,
it was not possible to recruit a second general prac-
tice within one of the trust areas into the study. Data
saturation was reached after 13 GP interviews and 14
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community pharmacist interviews. The additional in-
terviews with each HCP group were conducted before
a more detailed analysis was completed, and the point
of data saturation was established. The duration of in-
terviews varied amongst GP (range 32–84 min) and
pharmacist (range 26–101 min) participants.
Summary of findings from analysis at the level of
theoretical domains
The factors within each of the domains that were per-
ceived to influence the prescribing and dispensing of ap-
propriate polypharmacy to older people are summarised
below.
Clinical experience (‘Nature of the behaviours’) was a
key factor that facilitated HCPs in ensuring that older
patients received appropriate polypharmacy. This was
perceived to have an important influence on a number
of other domains. For example, HCPs frequently referred
to the role of clinical experience in developing their clin-
ical knowledge (‘Knowledge’), competencies (‘Skills’) and
professional confidence (‘Beliefs about capabilities’), all
of which helped them to ensure that older patients re-
ceived appropriate polypharmacy.
“…experience is the thing that teaches you the most
because it’s the thing that you tend to remember…”
PCT2
“I think the confidence comes from experience.” GP2
Both groups of HCPs reported that ensuring that
older patients received appropriate polypharmacy was
part of their professional role (‘Social/professional role
and identity’) and they were aware of the potential
for adverse outcomes (e.g. side-effects, drug interac-
tions, non-adherence) if actions were not taken to
improve appropriate polypharmacy in this patient co-
hort (‘Beliefs about consequences’).
“…ultimately the buck stops with me.” GP2
“I know it’s easier to just go, ‘Oh should I just give it
out or whatever’, but… you’re the one giving it out, I
think you do have responsibility to, if you think
something’s not appropriate, to double check.” PCT1
Routine procedures within daily practice enabled HCPs
to ensure that patients received appropriate polypharmacy
(‘Nature of the behaviours’). These included monitoring
and reviewing patients’ medication usage on an ongoing
basis. However, for a number of HCPs, their levels of at-
tention (‘Memory, attention and decision processes’) and
commitment (‘Motivation and goals’) to carrying out these
procedures as part of routine practice were lacking, par-
ticularly in light of existing time and workload barriers
(‘Environmental context and resources’).
“…it's possible that things are overlooked in a busy day
to day practice.” GP9
“If somebody comes in about four other things, and
you’ve got 10 minutes to see them in– it probably
becomes, honestly probably becomes less of a priority…
I think it’s not a fixed priority.” GP14
“…there's no money involved in addressing
polypharmacy, you know, you could be completely
cynical and turn round and go, ‘This patient gets 12
items, I get paid 98p for each item I dispense. Why
do I want to go out and tell this man he only
needs seven of them?’” PCT2
Pharmacists were mindful of professional boundaries
with GPs in recommending changes to older patients’
existing prescriptions (‘Social/professional role and
identity’), and some doubted their ability to have rec-
ommended medication changes implemented by GPs
(‘Beliefs about capabilities’). In contrast, GPs viewed
teamwork with pharmacists favourably (‘Social influences’/
‘Social/professional role and identity’). Based on their expe-
riences with local community pharmacists or having had
dedicated practice pharmacists to review prescribing
practices, GPs considered pharmacists to be both an
important resource (‘Environmental context and re-
sources’) and an integral component of any strategy
to improve appropriate polypharmacy in older people
(‘Behavioural regulation’).
“…pharmacists seem to be very well clued into it all
already, you know, and I think they’re probably going
Table 1 Participant demographics
General practicesa
(n = 9)
Community pharmacies
(n = 15)
Participant gender
Male 10 7
Female 5 8
Years of professional
experience (range)
3–27 3–32
Healthcare trust area
1 4 4
2 1 2
3 3 3
4 3 2
5 4 4
a>1 GP participant was recruited from five general practices
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to be main kind of stakeholders as well in reducing
polypharmacy…” GP4
“…it doesn’t necessarily have to be a doctor doing it,
and em, I think sometimes the pharmacists look at
things in a different way than we do… it’s a different
kind of focus you have on things…” GP14
“I think very often GPs eh or GP surgeries don’t often,
value the intervention, interaction and, that is
frustrating, continues to be frustrating, and I don’t see
any improvement in it in the last 25 years of working.
Don’t see any improvement in it at all, in fact I would
say quite probably the reverse…” PCT10
GPs outlined challenges in terms of professional
boundaries with hospital prescribers and some GPs
were reportedly unwilling to challenge recommenda-
tions from secondary care (‘Social/professional role and
identity’).
“…there are few GPs who will challenge the
recommendations of a specialist and if they say, ‘Add
in this, add in that’, they will often get added.” GP11
Both HCP groups reported a number of groups that
had variable influences on their clinical behaviour
(‘Social influences’). The specific influence of patients
and other HCPs varied according to the individual
participant. GP receptionists were perceived as a bar-
rier to ensuring that older patients received appropri-
ate polypharmacy owing to difficulties encountered by
pharmacists in making direct contact with GPs.
“I mean another barrier I suppose is sometimes due to
the receptionists in surgeries as well. Getting them to
buy into the fact that clinical decisions should be taken
between healthcare professionals, like pharmacists,
nurses, doctors and not taken by receptionists which I
find is happening a lot.” PCT15
In a similar manner, GPs reported the influence of pre-
scribing advisors as a barrier to ensuring that patients
received appropriate polypharmacy.
“…the barriers that come up to us for polypharmacy is,
em, a lot of it is created from our prescribing advisors,
to try and get us to get patients off, you know,
medications and switch to other appropriate
medications.” GP2
Both HCP groups reported that they had the neces-
sary clinical knowledge (‘Knowledge’) and skills/com-
petencies (‘Skills’) to review older patients’ medications.
This enabled them to ensure that patients received ap-
propriate polypharmacy. However, some GPs discussed
the challenges of applying available evidence and guide-
line recommendations in the context of older patients
(‘Knowledge’/‘Skills’).
“There might be evidence for each individual drug
but, you know, I don’t think there’s– there’s no
randomised controlled trials on, you know, what all
those drugs in combination do and, you know, there
aren’t going to be.” GP1
“Guidelines tend to be very disease-specific but how do
you do something? How do you prescribe for somebody
who has comorbidities and the guideline would seem
to be talking against each other, and so we need
the– where is the evidence base for telling people to
do then?” GP8
The main barriers that hindered both HCP groups in
ensuring that older patients received appropriate poly-
pharmacy related to the current work environment
(‘Environmental context and resources’). For example,
in addition to time and workload barriers, a lack of appro-
priate resources (e.g. staff) was also noted by both groups.
Pharmacists raised other challenges that they encountered
in practice (e.g. lack of direct communication network with
GPs, lack of access to patients’ clinical data, lack of avail-
ability of non-pharmacological treatment options).
“…it’s a mountain of work and the reason why it’s not
being done is because it’s not being resourced and
there’s no money to do it.” GP11
As previously noted, barriers identified under the ‘En-
vironmental context and resources’ domain impacted
negatively on other domains (e.g. Memory, attention
and decision processes, Motivation and goals). Various
resources and practical strategies were outlined by both
groups that either helped them in current practice (e.g.
computer support systems) or would be helpful in the
future (e.g. additional support staff ). Limitations of exist-
ing computer support systems and information resources
[e.g. British National Formulary (BNF), a standard refer-
ence text] were noted, particularly in terms of their clinical
relevance and application in the context of older patients
receiving polypharmacy.
“....quite often the computer's flagging up ones that
there isn't really an interaction.” PCT5
“…sometimes what’s in the BNF is not really enough.
It does not match having a detailed past experience
of prescribing something.” GP 1
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‘Emotion’ was the least frequently discussed domain
and was not perceived to have an important influence
on either group’s clinical behaviour.
Identification of key domains
Based on the research team’s review of the summary
findings from each dataset, all of the domains except for
‘Emotion’ were considered to be relevant to the prescrib-
ing and dispensing of appropriate polypharmacy to older
patients. Using the methods previously described,
eight key domains were selected to be targeted as part
of an intervention involving GPs and/or community phar-
macists: ‘Skills’, ‘Beliefs about capabilities’, ‘Beliefs about
consequences’, ‘Environmental context and resources’,
‘Memory, attention and decision processes’, ‘Social/
professional role and identity’, ‘Social influences’ and
‘Behavioural regulation’.
Mapping of theoretical domains to BCTs
Using previous work on mapping BCTs to the TDF [15,
16], as already outlined, the research team identified and
selected four BCTs for inclusion in a future intervention
involving GPs and/or community pharmacists to im-
prove appropriate polypharmacy in older people: ‘Action
planning’, ‘Prompts/cues’, ‘Modelling or demonstrating of
behaviour’ and ‘Salience of consequences’.
‘Social support or encouragement’ was selected as an
additional BCT for inclusion in the community pharmacy-
based intervention. This BCT mapped to both ‘Social/pro-
fessional role and identity’ and ‘Social influences’ and was
specifically included to target the professional boundary
and team working-related issues that were identified in
the community pharmacist interviews
Details of the mapping process used to select BCTs to
target mediators identified within the key domains are
provided in Table 2. It must be noted that the ‘Nature of
the behaviours’ domain is distinct from the other theoret-
ical domains as it relates to the key characteristics of the
behaviour of interest as opposed to potential mediating
mechanisms or influences [13, 27]. Hence, it was not in-
cluded in the original BCT mapping exercise undertaken
by Michie et al. [15], nor was it included in the mapping
exercise that was conducted in the current project. It was
intended that the habitual processes that were coded
under this domain would be modified indirectly by
targeting other causal aspects of the target behaviours
(i.e. the other key domains) using selected BCTs [28].
Discussion
This study forms part of a systematic approach to de-
velop an intervention to improve appropriate polyphar-
macy in older people in primary care that was modelled
on the MRC framework [12]. This type of approach has
been found to be lacking in the related literature [11].
The study advances application of the MRC framework
in the intervention development phase as initial explora-
tory work was undertaken with GPs and community
pharmacists as two groups of stakeholders that play key
roles in the provision of medication to older people in
primary care. The TDF [13] was used as an underpin-
ning theoretical model to gather comprehensive insights
into the clinical behaviours that need to be targeted in
order to achieve appropriate polypharmacy. This provides
the foundation for developing a theory- and evidence-
based intervention using specific behaviour change
techniques (BCTs) to target key mediators (i.e. barriers,
facilitators) of behaviour change.
With the exception of the ‘Emotion’ domain, all of
the theoretical domains were considered relevant to
the target behaviours (i.e. prescribing and dispensing
of appropriate polypharmacy). This illustrates the complex
nature of the target behaviours, as well as the challenge
faced by researchers in identifying key domains to target
when developing interventions to change these behav-
iours. In selecting key domains, we noted that barriers
within a number of domains could not realistically be ad-
dressed as part of the current project, such as the lack of
available evidence and guidelines to support prescribing
for older people with multimorbidity (i.e. barriers within
the ‘Knowledge’ domain). Thus, we purposefully selected
domains that would assist HCPs in taking action to ensure
that patients were prescribed/dispensed appropriate poly-
pharmacy (e.g. ‘Skills’, ‘Beliefs about capabilities’) as part of
routine clinical practice (‘Nature of the behaviours’). The
importance of the same group of key domains for both
HCP groups highlights commonalities in the perceived
mediators of behaviour change within each group. For ex-
ample, the sense of professional responsibility (‘Social/pro-
fessional role and identity’) expressed by members of both
professions in ensuring that patients received appropriate
polypharmacy facilitated HCPs in taking action to insti-
gate medication changes where necessary. However, it
must be noted that despite identification of similar chal-
lenges within a number of domains (e.g. time and work
environment pressures under the ‘Environmental context
and resource’ domain), perceptions of other domains as a
barrier or facilitator differed between the groups. For ex-
ample, each group’s perceptions differed as to the exist-
ence of interprofessional boundaries within primary care
(‘Social/professional role and identity’).
Due to the selection of the same key domains, an
overlap in the BCTs that would form the components
of an intervention involving GPs and/or community
pharmacists was expected (Table 2). Given the identi-
fied challenges relating to the current work environ-
ment (e.g. time and resource limitations), as well as
the lack of available evidence comparing the effective-
ness of BCTs in targeting specific theoretical domains,
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Table 2 Mapping of behaviour change techniques (BCTs) to key domains for inclusion in an intervention to improve appropriate
polypharmacy in older people
Domain BCTs identified from
Cane et al. 2015 [16]
Additional BCTs identified from
mapping matrix [15]
Selected BCTs as proposed intervention
components (including reasons to justify
exclusion of other BCTs)
Skills 1. Graded tasks
2. Behavioural rehearsal/practice
3. Habit reversal
4. Body changes
5. Habit formation
6. Goal/target specified: behaviour
or outcome
7. Monitoring
8. Self-monitoring
9. Rewards; incentives
(inc Self-evaluation)
10. Graded task: start with easy
tasks
11. Increasing skills: problem
solving, decision making, goal
setting
12. Rehearsal of relevant skills
13. Modelling/demonstration of
behaviour by others
14. Homework
15. Perform behaviour in different
settings
Modelling/demonstration of behaviour by
others (BCT 13): HCPs would be provided with a
demonstration of how to prescribe/dispense
appropriate polypharmacy during a typical
encounter/consultation with an older patient.
Reasons for not selecting other BCTs
BCTs 1, 2, 3, 5, 7, 8, 10, 12, 14: likely to
require repeated administration and/or
extended time periods to effect required
changes in target behaviours.
BCT 4: not applicable as a direct change to
HCPs’ body structure/functioning is unlikely to
have an impact on the target behaviours
(i.e. prescribing/dispensing of appropriate
polypharmacy).
BCT 6: not possible to establish an
acceptable goal/target in terms of the
number of older patients that HCPs would
perform target behaviours on because
ideally the target behaviours should be
performed on all older patients.
BCT 9: not within scope of project to offer
rewards/incentives and a general practice-
based incentive scheme already exists in UK
(i.e. the Quality and Oucomes Framework).
BCT 11: intervention would likely need
to be tailored to individual HCPs to
account for baseline variation in skill levels.
BCT 15: not applicable as the intervention
will target HCPs in their normal place of work
(i.e. general practice, community pharmacy)
and the intervention will focus on the
prescribing/dispensing of appropriate
polypharmacy to community dwelling older
patients as opposed to patients in other
settings (e.g. nursing homes) whose clinical
complexity and context is likely to be very
different.
Beliefs about capabilities 1. Verbal persuasion to boost
self-efficacy
2. Focus on past success
3. Self-monitoring
4. Graded task: start with easy
tasks
5. Increasing skills: problem solving,
decision making, goal setting
6. Coping skills
7. Rehearsal of relevant skills
8. Social processes of encouragement,
pressure, support
9. Modelling/demonstration of
behaviour by others
10. Homework
11. Perform behaviour in different
settings
Social processes of encouragement,
pressure, support (BCT 8): mapped to
‘Social/professional role and identity’
and ‘Social influences' – see below.
Modelling/demonstration of behaviour
by others (BCT 9): outlined above – see
‘Skills’ domain.
Reasons for not selecting other BCTs
BCTs 3, 4, 10: likely to require repeated
administration and/or extended time
periods to effect required changes in
target behaviours.
BCT 1: intervention would likely need to be
tailored to individual HCPs to account for
baseline variation in self-efficacy levels.
BCT 2: not suitable due to potential
variation in experience amongst HCPs
(i.e. if HCPs do not have previous experience of
performing the target behaviours then this BCT
will not apply to them).
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Table 2 Mapping of behaviour change techniques (BCTs) to key domains for inclusion in an intervention to improve appropriate
polypharmacy in older people (Continued)
BCTs 5, 6, 7: intervention would likely need
to be tailored to individual HCPs to account
for baseline variation in skill levels.
BCT 11: not applicable as the intervention
will target HCPs in their normal place of work
(i.e. general practice, community pharmacy) and
the intervention will focus on the prescribing/
dispensing of appropriate polypharmacy to
community dwelling older patients as opposed
to patients in other settings (e.g. nursing
homes) whose clinical complexity and context
is likely to be very different.
Beliefs about
consequences
1. Emotional consequences
2. Salience of consequences
3. Covert sensitization
4. Anticipated regret
5. Social and environmental
consequences
6. Comparative imagining of
future outcomes
7. Vicarious reinforcement
8. Threat
9. Pros and cons
10. Covert conditioning
11. Self-monitoring
12. Persuasive communication
13. Information regarding behaviour,
outcome
14. Feedback
Information regarding behaviour, outcome/
salience of consequences (BCTs 2 and
13 - equivalent): as part of the demonstration of
how to prescribe/dispense appropriate
polypharmacy during a typical encounter/
consultation with an older patient, positive
feedback would be included from the HCPs
and patients to emphasise the positive
consequences of performing the behaviour.
Reasons for not selecting other BCTs
BCTs 7, 10, 11, 14: likely to require repeated
administration and/or extended time periods
to effect required changes in target
behaviours.
BCT 1: emotional consequences of
performing the target behaviours have not
been established.
BCTs 3, 4: not applicable as intervention is
focussed on wanted behaviours as opposed
to unwanted behaviours.
BCT 5: not applicable as HCPs were already
aware of the consequences of performing the
target behaviours.
BCT 6: intervention would likely need to be
tailored to individual HCPs as the imagining
and comparing of future outcomes of
changed versus unchanged behaviour is
likely to vary between individuals.
BCT 8: not within scope of project to
implement future punishment or removal
of reward as a consequence of HCPs
performing an unwanted behaviour.
BCT 9: intervention would likely need to be
tailored to individual HCPs because if advised
to identify and compare pros and cons of
performing the target behaviours,
assessments are likely to vary between
individuals.
BCT 12: difficult to have a credible source
present evidence-based arguments in favour of
the target behaviours as few interventions to
date have examined clinically relevant
outcomes (e.g. hospital admissions, ADEs)
and where these outcomes have been
evaluated, the findings have been
inconsistent.
Environmental context
and resources
1. Restructuring the physical
environment
2. Discriminative (learned) cue
3. Prompts/cues
6. Environmental changes
(e.g. objects to facilitate
behaviour)
Prompts/cues (BCT 3): HCPs will be asked to
arrange for support staff (e.g. receptionists,
pharmacy technicians) to prompt them to
check that older patients who meet specific
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Table 2 Mapping of behaviour change techniques (BCTs) to key domains for inclusion in an intervention to improve appropriate
polypharmacy in older people (Continued)
4. Restructuring the social
environment
5. Avoidance/changing exposure
to cues for the behaviour
criteria are prescribed/dispensed appropriate
polypharmacy when patients present in the
practice/pharmacy.
Reasons for not selecting other BCTs
BCT 1: not within scope of project to
restructure HCPs’ physical work environment.
BCTs 2: not within scope of project to
offer reward (e.g. monetary fee) for
performing target behaviour).
BCT 4: not within scope of project to
restructure HCPs’ social environment.
BCT 5: not applicable as intervention is
seeking to promote performance of
target behaviours by HCPs as opposed to
avoiding/reducing exposure to cues for
the target behaviours.
BCT 6: not within scope of project to
restructure HCPs’ physical work environment.
Memory, attention and
decision processes
None 1. Self-monitoring
2. Planning, implementation
3. Prompts, triggers, cues
Planning, implementation (BCT 2;
equivalent to Action planning): HCPs
would be asked to write an explicit plan
of when and how they would ensure
that patients meeting inclusion criteria
are prescribed/dispensed appropriate
polypharmacy.
Prompts, triggers, cues (BCT 3): outlined
under ‘Environmental context and
resources’ domain.
Reasons for not selecting other BCTs
BCT 1: likely to require repeated
administration and/or extended time
periods to effect required changes in
target behaviours.
Social influences 1. Social comparison
2. Social support or
encouragement (general)3.
Information about others'
approval
4. Social support (emotional)
5. Social support (practical)
6. Vicarious reinforcement
7. Restructuring the social
environment
8. Modelling or demonstrating
the behaviour
9. Identification of self as role
model
10. Social reward
11. Social processes of
encouragement, pressure,
support
12. Modelling/demonstration
of behaviour by others
Social processes of encouragement,
pressure, support/ Social support or
encouragement (BCT 2, 11 - equivalent):
Pharmacists would receive a list of
pre-approved patients from the GP
practice which would encourage/support
them in engaging with patients to ensure
that they are dispensed appropriate
polypharmacy.
Modelling /demonstration of behaviour
by others/ Modelling or demonstrating
the behaviour (BCT 8, 12 - equivalent):
outlined above – see ‘Skills’ domain.
Reasons for not selecting other BCTs
BCTs 6, 9, 10: likely to require repeated
administration and/or extended time periods to
effect required changes in target
behaviours.
BCT 1: difficult to draw meaningful
comparisons between HCPs’
performance of target behaviours.
BCT 3: difficult to establish older patients’
views on HCPs performing target behaviours
due to clinical heterogeneity amongst older
patients who are receiving polypharmacy
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we prioritised BCTs that were unlikely to need re-
peated administration/delivery on a large number of
occasions or over extended time periods to elicit re-
quired changes in the target group’s behaviour. In this
way, ‘Modelling/demonstration of behaviour by others’
was chosen over other BCTs, such as ‘Graded tasks’,
to target the ‘Skills’ domain. We also purposefully
kept the number of BCTs to a minimum in order to
ensure that any proposed intervention would be feas-
ible to deliver to HCPs with high fidelity. We felt that
this would be preferable on account of both the exist-
ing time constraints within HCPs’ current work envir-
onment and the lack of available evidence to support
multifaceted interventions (i.e. an intervention includ-
ing two or more components) over single-component
interventions in changing HCPs’ behaviours [29]. A
future paper will outline different ways to operational-
ise the selected BCTs to design the intervention.
This study has raised two important methodological
issues regarding the development of TDF-based inter-
ventions targeting HCPs’ clinical behaviours. Firstly,
we based our interpretation of the domains on defini-
tions that were used in previous studies [22, 30].
Thus, in our interpretation of the ‘Nature of the be-
haviours’ domain, we coded references to ‘clinical ex-
perience’ in the interview transcripts to this domain
because ‘Direct experience/past behaviour’ is listed as
a theoretical construct under this domain. However,
other authors have published additional definitions for
each of the 14 theoretical domains of the most recent
version of the TDF [16], as well as a separate defin-
ition of the ‘Nature of the behaviours’ domain [31].
Despite the intended purpose of the TDF to simplify
psychological theory and make it more accessible to
researchers [13], the lack of a single reference source of
agreed definitions creates challenges in operationalising
Table 2 Mapping of behaviour change techniques (BCTs) to key domains for inclusion in an intervention to improve appropriate
polypharmacy in older people (Continued)
in terms of clinical conditions and
medication types.
BCTs 4, 5: encapsulated by BCT 2.
BCT 7: not within scope of project to
restructure HCPs’ social environment.
Behavioural regulation 1. Self-monitoring of behaviour 2. Goal/target specified: behaviour
or outcome
3. Contract
4. Planning, implementation
5. Prompts, triggers, cues
6. Use of imagery
Planning, implementation (BCT 4;
equivalent to Action planning): see under
‘Memory, attention and decision processes’
domain above.
Prompts, triggers, cues (BCT 5): see under
‘Environmental context and resources’
domain above.
Reasons for not selecting other BCTs
BCT 1: likely to require repeated
administration and/or extended time
periods to effect required changes in
target behaviours.
BCT 2: not possible to establish an
acceptable goal/target in terms of the
number of older patients that HCPs
would perform target behaviours on
because, ideally, the target behaviours
should be performed on all older
patients.
BCT 3: not within scope of current project
to impose additional contractual obligations
on HCPs.
BCT 6: used in the context of implementing
other BCTs through the use of planned images
(visual, motor, sensory); not applicable in the
context of this research project.
Social/professional role
and identity
None 1. Social processes of
encouragement, pressure,
support
Social processes of encouragement,
pressure, support (BCT 1): see under
‘Social influences’ domain above.
Nature of the
behaviours
No BCTs were mapped to this domain because it was not included in the original BCT mapping matrix [15]. It was intended
that this domain would be targeted indirectly using the selected BCTs that were mapped to the other seven key domains.
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the TDF [32]. A single reference source with domain defi-
nitions, as well as illustrative examples of how domains
can be operationalised during data collection and analysis,
would be invaluable to researchers to ensure consistency
in the interpretation and application of the TDF across
studies. It would be important for any future reference
source to include both versions of the TDF as the 12 do-
main version is still in use [19, 33, 34], and ongoing re-
search suggests that it may be more applicable than the 14
domain version in developing a generic TDF-based ques-
tionnaire [23].
Secondly, our study highlights the challenge faced by re-
searchers in selecting BCTs to target particular theoretical
domains where there is a lack of agreement or guidance in
the literature. Although the mapping work by Cane et al.
[16] provided up-to-date guidance for most of the map-
ping process, it did not help us in selecting BCTs to target
two key domains: ‘Memory, attention and decision pro-
cesses’ and ‘Social/professional role and identity’. We
sought to overcome this limitation by comparing the re-
sults of the mapping process against the original mapping
matrix that was developed by Michie et al. [15]. It must be
noted that there is, at present, no single best approach to
map BCTs to theoretical domains. Given the lack of con-
sensus amongst experts in the field in mapping BCTs to
particular theoretical domains [15, 16], it is only after suit-
ably designed experimental studies are conducted that re-
searchers will have a clearer understanding as to which
BCTs are effective in targeting specific domains. In the in-
terim, we contend that the use of both reference sources
provides a useful strategy to guide BCT selection.
Strengths and limitations
In reporting the systematic approach that we used to
identify key theoretical domains and to select BCTs as
part of our intervention development programme, we
have followed existing recommendations by being expli-
cit about our underlying reasons and rationale [18, 35].
This should facilitate other researchers and practitioners
in understanding how the underpinning theoretical
framework was used to guide intervention development.
In addition to identifying mediators of behaviour
change to target as part of the intervention, the inter-
views also provided valuable information about the
clinical context in which the behaviours are currently
performed. This information will be used to inform
selection of intervention approaches as part of the
feasibility screening process that will be outlined in a
future paper. For example, given the notable limitations of
existing computer-based prescribing alerts (‘Environmen-
tal context and resources’), such as lack of clinical rele-
vance, it is unlikely that a computer-based intervention
approach will be pursued. Another strength of this study
was the inclusion of a health psychologist (JF) with expert
knowledge of the TDF as part of the research team. This
helped to ensure effective use of the TDF (i.e. topic guide
development, data analysis) and that domains were not
interpreted superficially [27]. As a further step to help
overcome the challenge in clarifying boundaries between
domains, all data were analysed independently by at least
two members of the research team. This added to the val-
idity and reliability of the coding process.
Limitations must be noted with the research design
and sampling approach. As a qualitative study, the find-
ings are not readily generalisable to the wider population
of HCPs. However, participants were sampled across
Northern Ireland, and the spread of geographical locations
enhances the transferability of the findings. It must also be
noted that participants comprised a self-selected sample,
and participation was incentivised. Another limitation is
that the findings reflect participants’ perceptions/attribu-
tions of influences on their clinical behaviours as opposed
to actual causes [27]. In addition, clinicians’ beliefs regard-
ing appropriate clinical practices may not necessarily
translate into action at the individual patient level [36].
Conclusions
The study findings highlight the range of theoretical
domains that were perceived to influence HCPs when
prescribing and dispensing appropriate polypharmacy
to older people in primary care and, hence, the com-
plex nature of the target behaviours. There was a
considerable overlap in terms of the key domains that
were perceived to affect both HCP groups’ behav-
iours, and a number of common BCTs were selected
for inclusion in a future intervention involving GPs
and/or community pharmacists. Selected BCTs pro-
vide a foundation for developing a theory-based inter-
vention to improve appropriate polypharmacy in older
people in primary care. Future work will involve develop-
ing an intervention using selected BCTs for further feasi-
bility testing before any larger scale trial evaluation is
undertaken.
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